Skip to main content

Krishnan Krish S's Form 4 filing

Krystal Biotech, Inc. (KRYS) · filed Jun 5, 2026

Accession no.
0001298709-26-000009
Filed
Jun 5, 2026
Trade date
Jun 4, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 11 non-derivative transactions. Open-market sales total $7.70M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krishnan Krish SCIK 0001298709Director, Officer (President and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 4, 2026Common StockSSaleDisposed−320$300.75−$96,2401,474,933Direct
Jun 4, 2026Common StockSSaleDisposed−640$302.24F3−$193,433.61,474,293Direct
Jun 4, 2026Common StockSSaleDisposed−176$303.17F4−$53,357.921,474,117Direct
Jun 4, 2026Common StockSSaleDisposed−544$304.81F5−$165,816.641,473,573Direct
Jun 4, 2026Common StockSSaleDisposed−589$306.33F6−$180,428.371,472,984Direct
Jun 4, 2026Common StockSSaleDisposed−11,461$307.68F7−$3,526,320.481,461,523Direct
Jun 4, 2026Common StockSSaleDisposed−4,830$308.47F8−$1,489,910.11,456,693Direct
Jun 4, 2026Common StockSSaleDisposed−2,784$309.49F9−$861,620.161,453,909Direct
Jun 4, 2026Common StockSSaleDisposed−2,652$310.43F10−$823,260.361,451,257Direct
Jun 4, 2026Common StockSSaleDisposed−964$311.36F11−$300,151.041,450,293Direct
Jun 4, 2026Common StockSSaleDisposed−40$312.23−$12,489.21,450,253Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The transaction was executed in multiple trades ranging from $302.05 to $303.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F4

The transaction was executed in multiple trades ranging from $303.05 to $303.82. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F5

The transaction was executed in multiple trades ranging from $304.07 to $304.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F6

The transaction was executed in multiple trades ranging from $306.00 to $306.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F7

The transaction was executed in multiple trades ranging from $307.03 to $308.02. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F8

The transaction was executed in multiple trades ranging from $308.03 to $309.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F9

The transaction was executed in multiple trades ranging from $309.04 to $310.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F10

The transaction was executed in multiple trades ranging from $310.06 to $311.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F11

The transaction was executed in multiple trades ranging from $311.07 to $311.77. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)